INS and type 2 diabetes mellitus: This detailed analysis of a large data set using rigorous modern statistical methods and machine learning suggests that adults with type 2 diabetes who are new users of human or analogue insulin have similar rates of mortality, CVD mortality, and major cardiovascular events during 2.5 years of follow-up.